España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Recent
Markets
Ladenburg Thalmann
ElectroCore Analyst: Nerve Stimulation Market Opportunity Is Large
Are You Following Analysts On These Penny Stocks?
Marinus Pharmaceuticals Has 3 Major Catalysts In 2018, Ladenburg Thalmann Says In Bullish Initiation
Are You Following Analysts On These Penny Stocks?
Marinus Pharmaceuticals Has 3 Major Catalysts In 2018, Ladenburg Thalmann Says In Bullish Initiation
Analyst: Sage Therapeutics Holds A Breakthrough In Depression Treatment
Analyst: Entrectinib's Potential Gives Ignyta's Stock 116% Upside
Analyst: Sage Therapeutics Holds A Breakthrough In Depression Treatment
Analyst: Entrectinib's Potential Gives Ignyta's Stock 116% Upside
Can Novavax Stage A Comeback In Q4? One Analyst Thinks So
Meet VBI Vaccines, The Biotech Up 100% In 2017
Read More...
Ladenburg Thalmann Recent News
Taser Says VieVu's Legal Complaint Is 'Frivolous'
Taser Records Solid Top-Line Results, Though Margins Appear Arrested
Is There Still A Path Forward For The Novovax RSV Vaccine?
Ladenburg Thalmann On Biotech: Buy BioCryst, Albireo Shares
Myriad Genetics' Sell Thesis Is 'Largely Played Out'
Ladenburg On Biotech: Starts Achillion, Alnylam, Corcept, Trevana At Buy
Ladenburg Downgrades Cempra Following FDA's Complete Response Letter
Ladenburg Sets A New Buy Rating, $85 Target On Anadarko
Cuban Opportunity: President Trump Vs. Castro's Death
Legal Overhangs Keep Ladenburg Neutral On Neovasc Despite Positive Tiara Clinical Data
Repros Therapeutics Shares Rally Following Ladenburg Upgrade To Buy, Positive Data
XOMA Challenged With A 'Major Financing Overhang'
Taser's Top Line Was Impressive And Investors Responding In Part, But Competition Concerns Remain
Kindred Biosciences Is 'Setting The Pace In Animal Health Biologics'
Chesapeake's 4-Prong Strategy To Reduce Debt And Kick Start Growth
Ladenburg Thalmann Positive On TG Therapeutics Post Adjustments To GENUINE Study
Analyst Upgrades Capitala Finance On Dividend Alignment, De-Risked Portfolio
Taser Could Soon Be Facing Increased Price Competition
Ladenburg Thalmann Says Newly Merged Apple Hospitality REIT Could See Weakness Near Term
Ladenburg Thalmann Initiates Spire With A Neutral Rating, $69 Target
Spark Energy Is A 'Pure Play Competitive Retailer'
Medley's Growth Initiatives Are Already Priced Into The Stock
Metal-Mesh Sensors Are The Key To Uni-Pixel's Growth